On 1 April 2008, Advocate General Colomer gave his opinion in Joined Cases C-468/06 to C-478/06 Sot. Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE.The case relates to a long series of disputes in Greece where GlaxoSmithKline has been accused of abusing its dominant position by reducing supplies of pharmaceutical products to wholesalers. In his opinion, Advocate General Colomer concluded that a refusal by a dominant company to meet the orders of wholesalers in order to limit parallel trade constitutes an abuse unless it can be objectively justified. In the present case, the Advocate General did not accept GlaxoSmithKline’s attempts to justify the refusal to supply on the basis of either the regulated pricing system for pharmaceutical products, or the legal duty to service the
Share on
|
|
The EU Court of Justice Advocate General Colomer gives his opinion on abuse of dominant position in the pharmaceutical sector (Lélos kai Sia)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
